Lesson plan
2C-EF-FLY
2C-EF-FLY is a psychedelic drug of the phenethylamine, 2C, and FLY families. It is the FLY (benzodifuran) derivative of 2C-EF and is a fluorinated derivative of 2C-E-FLY. The in-vitro metabolism of 2C-EF-FLY and its monoamine oxidase (MAO) interactions have been described. 2C-EF-FLY produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. It showed around half the potency of 2C-B-FLY and 2C-E-FLY in this assay, but was slightly more potent than 2C-I-FLY. 2C-EF-FLY was first described in the scientific literature by Lea Wagmann and colleagues in 2018 or 2019. It has been described as a novel designer drug.
Article summary
2C-EF-FLY is a psychedelic drug of the phenethylamine, 2C, and FLY families. It is the FLY (benzodifuran) derivative of 2C-EF and is a fluorinated derivative of 2C-E-FLY. The in-vitro metabolism of 2C-EF-FLY and its monoamine oxidase (MAO) interactions have been described. 2C-EF-FLY produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. It showed around half the potency of 2C-B-FLY and 2C-E-FLY in this assay, but was slightly more potent than 2C-I-FLY. 2C-EF-FLY was first described in the scientific literature by Lea Wagmann and colleagues in 2018 or 2019. It has been described as a novel designer drug.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.